CompoAtlas

Nattokinaza NSK-SDTM 100 mg

Food supplement declared in France, declaration No 2019-3-904, decision dated 20 March 2019

Nattokinaza NSK-SDTM 100 mg, from Kenay GmbH, is a food supplement declared in France. Status: declared in France, may be marketed. Main ingredients: Glycine max. 100 mg per day. 1 rule of use applies to its ingredients (limits and warnings).

Brand
not provided
Food business operator placing the product on the market
Kenay GmbH
Status
Declared in France, may be marketed: the authorities did not object to the declaration (this is neither an authorisation nor a safety assessment)
Form
Capsule
Daily dose
100 mg
Directions for use
1 gélule
Not recommended (according to the manufacturer)
Adolescents (under 18), Breastfeeding women, History of breast cancer, Children (under 12), Young children (aged 1 to 3), Pregnant women, Taking anticoagulants

Declaration 294361, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 15 November 2026.

Declared composition

Plants

PlantPartPreparationPer day
Glycine max. (L.) Merr.GraineAutre macérât100 mg

Additives

E475, E322, E422

Other ingredients

Cire d'abeille, Gélatine de porc, huile de soja

List from the declaration, administrative decision dated (Compl'Alim, food supplement declarations (France)).

Photograph the packaging

Label warnings

NNe pas dépasser la dose quotidienne recommandée. Les compléments alimentaires ne peuvent être utilisés comme substitut d'un régime alimentaire varié. Le complément alimentaire est destiné pour les adultes. Le produit ne doit pas être utilisé par les femmes enceintes et les femmes qui allaitent, ou les enfants et les adolescents de moins de 18 ans. Ne pas utiliser chez les femmes atteintes d'un cancer du sein ou d'un cancer du sein dans les antécédents familiaux. En cas de troubles de la coagulation sanguine, il est recommandé des consultations médicales. Le complément alimentaire ne doit pas être utilisé par des personnes allergiques au soja.

Regulatory points

This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.

Official warnings (Health Canada)

Health Canada publishes warnings on these ingredients:

They concern the ingredient, not this product or its dose. They do not replace medical advice.

Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.

Cite this page: CompoAtlas, “Nattokinaza NSK-SDTM 100 mg: composition and regulation”, https://compoatlas.com/en/supplements/products/294361-nattokinaza-nsk-sdtm-100-mg, updated 15 November 2026.

List recorded in 2019. Photograph the packaging to check whether it has changed.

Enter to analyse, Shift+Enter for a new line